Parkinsonâ€™s conferences | Neurology Conferences | Asiapacific | USA | Europe | Middle East | 2018 | 2018

Quick Links

Global Experts Meeting on Parkinsonâ€™s & Movement Disorders

Parkinsons congress 2018

Global Experts Meeting on Parkinsonâ€™s & Movement Disorders

Parkinsonâ€™s & Movement Disorders

Global Experts Meeting on Parkinsonâ€™s & Movement Disorders

Parkinsonâ€™s & Movement Disorders

Global Experts Meeting on Parkinsonâ€™s & Movement Disorders

Parkinsonâ€™s & Movement Disorders

Global Experts Meeting on Parkinsonâ€™s & Movement Disorders

Parkinsonâ€™s & Movement Disorders

Global Experts Meeting on Parkinsonâ€™s & Movement Disorders

Parkinsonâ€™s & Movement Disorders

Global Experts Meeting on Parkinsonâ€™s & Movement Disorders

Theme: Advanced Research and Progressions in Parkinsonâ€™s Disease

Parkinsonscongress-2018

Scientific Program

Parkinsonscongress-2018

Track 1: Parkinson ’s disease

Parkinson's sickness is a dynamic issue of the sensory system that influences development. It grows slowly, in some cases beginning with a scarcely detectable tremor in only one hand. However, while a tremor might be the most surely understood indication of Parkinson's infection, the turmoil likewise regularly causes solidness or moderating of development. In the early phases of Parkinson's illness, your face may indicate next to zero demeanour, or your arms may not swing when you walk. Your discourse may turn out to be delicate or slurred. Parkinson's malady indications compound as your condition advances after some time.

7^th Addiction Research Conference and Therapy, November 13-15, 2017 Las Vegas, USA; 5^th Neurological Disorders Conference and Stroke Conference, November 13-14, 2017 London, UK; 10^th Alzheimer’s Disease Congress and Dementia Congress, May 30-31, 2018 Osaka Japan; 11^th Vascular Dementia Conference February 22-23, 2018 Paris, France;20^th Neuroscience Conference and Neurochemistry Conference February 26-27, 2018 Berlin, Germany; Parkinson’s Disease Therapeutics Conference October 30, 2017 New York city USA; 13^th International Conference on Alzheimer’s & Parkinson’s Disorders, March 29-April 2 2017 Vienna, Austria; 5^th World Parkinson Congress, June 4-7 2019 Kyoto; Comprehensive Review of Movement Disorders for the Clinical Practitioner, August 1-4, 2017 Colorado USA;19^th International Conference on Parkinson’s Disease & Movement Disorders May 25-26 2017 London UK;; International Parkinson & Movement Disorder Society, Northwest Parkinson’s Foundation, American Neurological Association, World Parkinson Coalition, American Parkinson’s Disease Association.

Track 2: Epidemiology of Parkinson’s disease

Parkinson's sickness is one of the outstanding age related neurodegenerative issue, second in repeat just to Alzheimer's infection. Parkinson's malady likewise causes broad damage of the engine or tactile pathways stretching out past the pig mental cerebrum stem cores. In spite of the fact that the ailment side effects can be controlled by Levodopa yet the etiology of the Parkinson's illness stays cloud.

Track 3: Neuromuscular Disorders

Neuromuscular turmoil is an infection that influences the fringe sensory system which incorporates muscles, nerve-muscle intersection, and fringe nerves in the appendages and engine nerve cells in the spinal rope. Roughly 5600 individuals in the US are determined to have ALS every year. In US every year 750,000 individuals encounter stroke, 11000 individuals endure spinal line damage, 500,000 individuals experiencing cerebral paralysis, 270,000 with numerous sclerosis and 5.3 million with the after effects of horrendous mind damage and amyotrophic sidelong sclerosis.

Track 4: Alzheimer's Disease & Dementia

Alzheimer's is caused by cerebrum cell demise. It is a neurological issue in which the demise of cerebrum cells causes memory misfortune and intellectual decrease. The aggregate size of the cerebrum contracts in Alzheimer's, nerve cells and associations in the tissue logically lessened, which can't be seen or tried in the living mind influenced by Alzheimer's ailment, posthumous/post-mortem examination will dependably demonstrate little incorporations in the nerve tissues, called as plaques and tangles. Plaques are found between the diminishing cells in the mind - from the development of a protein called beta (amyloid plaques). The tangles exist in the mind neurons, from a breaking down of second protein, called tau.

Around the world, with Dementia or Related issue almost 44 million individuals have endured in 2015,past outcomes demonstrated 35.66 million populace lived with dementia worldwide in year 2010, with numbers anticipated that would about twofold every twenty years, to 65.7 million out of 2030 and 115.4 million out of 2050. In 2010, fifty eight for each penny of all populace with dementia lived in nations with lower or direct livelihoods, with this extent expected to ascend to 63% till 2030 and 71% by 2050. This condition is expected to twofold by 2030 and very triple by 2050 to 115 million.

Track 5: Anxiety and Depression

A great many people feel on edge or discouraged now and again. Losing a friend or family member, landing terminated from a position, experiencing a separation, and other troublesome circumstances can lead a man to feel tragic, desolate, frightened, apprehensive, or restless. These sentiments are typical responses to life's stressors.

Be that as it may, a few people encounter these emotions day by day or almost day by day for no evident reason, making it hard to continue with ordinary, regular working. These individuals may have an uneasiness issue, dejection, or both.

It is normal for somebody with a tension issue to likewise experience the ill effects of gloom or the other way around. About one-portion of those determined to have despondency are likewise determined to have a tension issue. Fortunately these clutters are both treatable, independently and together.

Track 6: Neuropsychiatric Disorders

Uneasiness and consideration deficiency hyperactivity issue (ADHD), are among the most every now and again analyzed of every single neuropsychiatric issue. Albeit many individuals can be treated with ordinary solutions, these medications regularly have undesirable reactions and might be redirected for illegal utilize. Researchers have made imperative commitments to our comprehension of the organic premise and pharmacological administration of tension and ADHD, and extra examinations have given new bits of knowledge into the pathophysiology and treatment of self-damaging conduct (SIB).

Track 7: Diagnosis for Parkinson’s Disease

Making an exact analysis of Parkinson's — especially in its initial stages — is troublesome, yet a gifted professional can arrive at a contemplated conclusion that it is PD. You may have encountered this dissatisfaction. Maybe it took years for you to get a finding. Maybe you have been analysed, however with Parkinsonism, not Parkinson's, and are befuddled about the suggestions.

The bedside examination by a neurologist remains the first and most imperative demonstrative apparatus for patients associated with having PD. At the point when questions emerge, some more up to date imaging modalities, for example, PET and DAT sweeps may help determination, when performed by a specialist in neuroimaging. DAT scan is FDA-affirmed for separating PD from fundamental tremor, however it can't recognize PD and parkinsonian subtypes.

Track 8: Managing life with Parkinson’s Disease

It is essential to develop a strong Parkinson’s disease administration design since Parkinson’s disease is an incessant sickness. Dealing with Parkinson’s malady incorporates building a human services group with appropriate specialists, legitimate admission of meds, activities, nourishment and rest.

Track 9: Neuroimaging

Neuroimaging or mind imaging is the utilization of different methods to either specifically or by implication picture the structure, work/pharmacology of the sensory system. It is a generally new train inside prescription, neuroscience, and psychology. Physicians who spend significant time in the execution and translation of neuroimaging in the clinical setting are Neuro Radiologists.

Neuroimaging falls into two general classifications:

Auxiliary imaging, which manages the structure of the sensory system and the analysis of gross (expansive scale) intracranial sickness, (for example, tumor) and damage. Practical imaging, which is utilized to analyse metabolic illnesses and sores on a better scale, (for example, Alzheimer's infection) and furthermore for neurological and intellectual brain science research and building cerebrum PC interfaces.

Track 10: Advanced therapies in Parkinson’s Disease

In cutting edge Parkinson's malady (PD), neurologists and patients confront an unpredictable choice for a propelled treatment. While picking a treatment, the best accessible proof ought to be joined with the expert's skill and the patient's inclinations. Objective: The target of this investigation was to investigate current basic leadership in cutting edge PD. Techniques: We led centre gathering exchanges and individual meetings with patients (N = 20) who had gotten profound cerebrum incitement, Levodopa-Carbidopa intestinal gel, or subcutaneous Apo morphine implantation, and with their guardians (N = 16).

Track 11: Movement Disorders

An utilitarian development issue implies that there is strange development or situating of part of the body because of the sensory system not working legitimately (but rather not because of a fundamental neurological sickness).

Track 12: Movement Disorders risk factors

Development Disorder can influence anybody at any age; in any case, young men are more influenced than young ladies. Stereotypic development issue generally influences youngsters who have mental impediment or are experiencing neurological disarranges.

ConferenceSeries is a renowned organization that organizes highly notable Neuroscience Conferences throughout the globe.

ConferenceSeries is currently bringing forth "4^th Global Experts Meeting on Parkinson’s & Movement Disorders" (Parkinson’s Congress 2018) slated on May 14-15, 2018 at Singapore. The conference invites all the participants across the globe to attend and share their insights and convey Advance Research in the field of Parkinson’s & Movement Disorders.

Exhibition:

Why exhibit?

Make sales
Debut new products
Profile your brand
Meet new business partners and suppliers
Develop key relationships
Educate Neuroscience institutions and academia

Who you will meet?

Neurosurgeons
Neurologists
Neuro physicians
Neuroscientists
Neuro Psychiatrists
Neuro Radiologists
Nutritional Scientists
Neuropsychologists
Neuro specialists
Neuropharmacologist
Neuropathologist
Neuroscience Nurses

Who should sponsor?

Neuroscience Societies
Neurology Research Institutes
Hospitals
Pharmaceuticals
Drug Manufacturers
Educational Institutes
Research Centers

Why you should attend?

Explore the idea that loss of cells in other areas of the brain and body contribute to Parkinson’s.
Risk factors for the development and progressions of Parkinson’s and Movement Disorders.
New Diagnostic Criteria for Parkinsons Disease.
Assessment in early stage Parkinsons Disease.
Latest Advancements in Parkinson’s Disorders.
Engage in the exciting event format, with round tables, panels, showcases, speed networking and multiple conference tracks.
Share experiences, insights and strategies in interactive peer-to peer round tables.
Hear more perspectives in one place – from large medium and small organisations from pharma, biotech and academia.

Parkinson’s congress-2018 invites all the participants from all over the world to attend the parkinsons congress-2018 conference entitled “4^th Global Experts Meeting on Parkinson’s & Movement Disorders” during May 14-15, 2018 Singapore. This gathering is predominantly will focus the most recent and energizing developments in each range of Parkinson’s research, and it will offer an exceptional opportunity for specialists from all over the world to meet, network, and distinguish with different scientific interactions.

Parkinson’s disease is a dynamic neurological disorder that influences how the individual moves, including how they talk and compose. This disease is caused by low dopamine levels. Various useful treatments, utilizing therapies (physiotherapy), surgery and medications have recognized neurological disorders and changes in the patient group. People with Parkinson’s disease also experience stiffness and they find abnormality in carrying out the movements as rapidly as before- this is known as bradykinesia.

The Parkinson’s disease market in US is expected to grow at a rate of 5.3% from sales of of $1.1 billion in 2012 to $1.3 billion in 2022. Approximately 1 million adults in Asia are suffering from Parkinson’s disease, from where 60,000 were diagnosed annually. An estimated of 30%-50% of PD patients mainly suffering from depression. United States is in the fourth position in considering the death of people due to Parkinson’s disease. African Americans have the highest death rate of 66.4% followed by whites of 64.6%, Hispanic with 55.4% and Asians with 50.8%. Parkinson’s disease strikes 50% more men than women. The economic burden of Parkinson’s disease on patients and their families in the Asia is about $9.4 billion.

Why to attend:

It is our great pleasure to welcome you to the “4^thGlobal Experts Meeting on Parkinson’s & Movement Disorders” during May 14-15, 2018 Singapore.

The Conference will encourage new discoveries and research by providing a platform for reporting of unique and unusual cases which enhance understanding of disease process, its diagnosis, management and clinic-pathologic correlations. It will provide a podium for wide-ranging aspects of psychological, neurological, molecular, genetic and behavioral pathways underlying addiction, and will focus on novel therapies providing quality care for people with unhealthy alcohol, tobacco, or other drug use and addictive behaviors across a spectrum of clinical settings. It will comprise of opening Keynote lectures by the renowned researcher and noble members working in the field of Neourology disorders research and treatment followed by the special workshop and symposium sessions by eminent scholars and therapeutic members for all the three days of the conference.

Target audience: Neurologists, Psychiatrists, Psychologists, Neurosurgeon, Head of the department, Director, Industries, Delegates, Clinical, Community members, Professors, Researchers, Students, Scientists, Nurses.

Neurologists and Directors
Physicians
Neuroscientists
Specialists
Researchers
Professors
Industrial Experts
Neurosurgeons
Psychiatrist
Nutritional Scientists
Lecturers and Students from Academia in the study of Parkinson disease
Students from Academia in the research of Neurology and Neuroscience
Therapists

Parkinson’s disease market is set to expand from $2.1 billion in 2014 to $3.2 billion by 2021, at a moderate Compound Annual Growth Rate (CAGR) of 5.7 percent, game-changing treatments will not be available for the foreseeable future, according to business intelligence provider GBI Research.

There are around 10 million individuals experiencing Parkinson's infection all around. Parkinson's, as far as its essence, has a higher recurrence in the created nations. In the United States (U.S.), around 60,000 new cases are determined to have Parkinson's, every year. Parkinson's malady is an idiopathic sickness happening because of obscure causes. By and by, just symptomatic medication medicines are accessible in the market. Additionally, these indications are analysed at later stages when the greater part of the dopamine creating cells have lost their capacity. This situation demonstrates a looming requirement for inventive medications.

The worldwide Parkinson's sickness showcase is divided on the premise of medication sort and topography. As per sedate sort, the market is portioned into, advertised and pipeline drugs. The showcased drugs are additionally divided into Levodopa, Dopamine agonists, Apomorphine, Glutamate rival, Anticholinergics, COMT inhibitors and MAO-B inhibitors. Topographically, the market is sectioned crosswise over four locales to be specific North America, Europe, Asia Pacific, and LAMEA.

The market for neurodegenerative confusion medicines can be separated into three portions: dynamic dementia, dynamic dementia with other neurological variations from the norm, and development issue.

Dynamic dementia medicines are relied upon to have an estimation of $7.3 billion out of 2012 and about $11 billion of every 2017, a CAGR of 8.4%.

Medicines for dynamic dementia with other neurological variations from the norm should add up to $537.2 million out of 2012 and $913.7 million out of 2017, a CAGR of 11.2%.

Medicines for development issue are relied upon to be worth $3.2 billion out of 2012 and $4.8 billion out of 2017, a CAGR of 8.3%.

In spite of energizing advances in the treatment of disorders of dementia and development issue amid the previous three years, a total therapeudic treatment or medication item has not been found to date. This is basically because of the diverse idea of the maladies and the way that the majority of their fundamental causes are as yet obscure or being contemplated. Various medication items are in the market; nonetheless, these medications are to a great extent for the symptomatic treatment of these sicknesses. Along these lines, there is an earnest requirement for medications for the neurodegenerative sicknesses influencing a huge number of individuals around the world.

Pick up a diagram of the present and future qualities of the worldwide markets for medicines for disorders of dementia and development issue

Breakdown incomes by neurodegenerative infection and essential clinical/neurotic component

Survey applications for medications and restorative advancements for disorders of dementia and development issue

Recognize the real players in the business destined to contend well now and into what's to come

Survey patent data pertinent to the business.

UNIVERSITIES IN SINGAPORE

Nanyang Technological University
Singapore Management University
SIM University
Singapore Institute of Technology
GlobalNxt University
Curtin Singapore
James Cook University Singapore
University of New South Wales Asia
Johns Hopkins in Singapore

Hospitals in Singapore

Alexandra Hospital
Changi General Hospital
Ng Teng Fong General Hospital
National University Hospital
Khoo Teck Puat Hospital
Singapore General Hospital
Tan Tock Seng Hospital
KK Women's and Children's Hospital

Companies Associated with Neurology in Singapore are

Farrer Park Company
Gleneagles
National Neuroscience Institute Sing health
Singapore Neurology Sleep centre
Parkway Pantai
Singapore Medical Group
Grifols Singapore

Major Associations around the Globe

Neuropathy Association
The brain & behavior research foundation
Alzheimer's Association
American Academy of Neurology
European Neurological Societies
World Federation of Neurology
Spanish Society of Neurology
Major Neurological Associations in Italy
Hilarescere Foundation in Italy
Italian MS society in Italy
Southern Clinical Neurological Society
ESNR European Society of Neuroradiology
Vision sciences society

Around 500 top universities globally working in the field of Neuroscience

Dalhousie University
Leiden University- Neither land
Temple University USA
University Oklahoma
Boston Coll USA
Florida International University
University California – Davis
University Sheffield
University Manchester
University of Nottingham
Cardiff University
University of Toronto – Canada
Hospitals Associated with Neuroscience Research

All around the globe there are 6000 hospitals working on Neurology

Some of them among them are:
Johns Hopkins Hospital
World Brain Center Hospital
Duke University Hospital
Edward Hospital
Munson Medical Center

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	May 14-15, 2018
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed	Day 1
Poster Opportunity Closed	Click Here to View